The safety and efficacy of indobufen or aspirin combined with clopidogrel in patients with acute myocardial infarction after percutaneous coronary intervention

Currently, the standard treatment for patients who have undergone percutaneous coronary intervention (PCI) following acute myocardial infarction (MI) involves dual antiplatelet therapy (DAPT) with a combination of aspirin and a potent P2Y12 receptor inhibitor. However, the potential benefits of aspi...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Wen-Bo Dai, Jia-Yi Ren, Su-Tao Hu, Yu-Kun Zhang, Tian-Shu Gu, Xue Wu, Jing-Kun Zhang, Jing-Jin Che, Xiang-Hong Ma, Tong Liu, Guang-Ping Li, Kang-Yin Chen
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Taylor & Francis Group 2024-12-01
Serie:	Platelets
Soggetti:	Acute myocardial infarction aspirin indobufen percutaneous coronary intervention
Accesso online:	https://www.tandfonline.com/doi/10.1080/09537104.2024.2364748
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!